Carcinoma
MONDO:0004993A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.
Also known as: epithelioma, Other carcinoma, carcinoma, carcinoma, malignant, epithelial carcinoma, epithelioma malignant, malignant epithelial neoplasm, malignant epithelial tumor
16928 clinical trials for this condition and its sub-types, 224 tagged with Carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Carcinoma
-
Adenocarcinoma 184 trials · 5,243 incl. sub-types
64 sub-types
- Hepatocellular carcinoma 1,043 trials · 1,088 incl. sub-types Sub-types →
- Pancreatic adenocarcinoma 493 trials · 926 incl. sub-types Sub-types →
- Renal cell carcinoma 611 trials · 710 incl. sub-types Sub-types →
- Tubular adenocarcinoma 0 trials · 557 incl. sub-types Sub-types →
- Colorectal adenocarcinoma 246 trials · 546 incl. sub-types Sub-types →
- Gastroesophageal junction adenocarcinoma 506 trials
- Gastric adenocarcinoma 448 trials · 480 incl. sub-types Sub-types →
- Bile duct adenocarcinoma 17 trials · 416 incl. sub-types Sub-types →
- Prostate adenocarcinoma 297 trials Sub-types →
- Breast adenocarcinoma 36 trials · 278 incl. sub-types Sub-types →
- Serous adenocarcinoma 6 trials · 241 incl. sub-types Sub-types →
- Ovarian adenocarcinoma 12 trials · 230 incl. sub-types Sub-types →
- Clear cell adenocarcinoma 14 trials · 201 incl. sub-types Sub-types →
- Esophageal adenocarcinoma 168 trials · 172 incl. sub-types Sub-types →
- Adenocarcinoma in situ 10 trials · 170 incl. sub-types Sub-types →
- Endometrioid adenocarcinoma 12 trials · 144 incl. sub-types Sub-types →
- Endometrium adenocarcinoma 30 trials · 118 incl. sub-types Sub-types →
- Thyroid gland adenocarcinoma 0 trials · 118 incl. sub-types Sub-types →
- Lung adenocarcinoma 114 trials · 117 incl. sub-types Sub-types →
- Gastroesophageal adenocarcinoma 93 trials
- Papillary adenocarcinoma 2 trials · 92 incl. sub-types Sub-types →
- Fallopian tube adenocarcinoma 4 trials · 81 incl. sub-types Sub-types →
- Small intestine adenocarcinoma 18 trials · 60 incl. sub-types Sub-types →
- Mucinous adenocarcinoma 18 trials · 57 incl. sub-types Sub-types →
- Adenoid cystic carcinoma 46 trials · 47 incl. sub-types Sub-types →
- Cervical adenocarcinoma 27 trials · 34 incl. sub-types Sub-types →
- Poorly differentiated thyroid gland carcinoma 17 trials
- Acinar cell carcinoma 4 trials · 15 incl. sub-types Sub-types →
- Signet ring cell carcinoma 4 trials · 11 incl. sub-types Sub-types →
- Paget disease 2 trials · 9 incl. sub-types Sub-types →
- Gallbladder adenocarcinoma 9 trials Sub-types →
- Bladder adenocarcinoma 5 trials · 8 incl. sub-types Sub-types →
- Vaginal adenocarcinoma 7 trials Sub-types →
- Cystadenocarcinoma 0 trials · 6 incl. sub-types Sub-types →
- Diffuse type adenocarcinoma 1 trial · 6 incl. sub-types Sub-types →
- Vulvar adenocarcinoma 3 trials · 5 incl. sub-types Sub-types →
- Parathyroid gland carcinoma 4 trials
- Pituitary adenocarcinoma 3 trials Sub-types →
- Sebaceous adenocarcinoma 2 trials · 3 incl. sub-types Sub-types →
- Hepatoid adenocarcinoma 2 trials Sub-types →
- Mesonephric adenocarcinoma 2 trials Sub-types →
- Sweat gland carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Urethra adenocarcinoma 1 trial · 2 incl. sub-types Sub-types →
- Follicular variant thyroid gland papillary carcinoma 1 trial
- Micropapillary serous carcinoma 1 trial
- Nasal cavity adenocarcinoma 1 trial
- Seminal vesicle adenocarcinoma 1 trial
- Trabecular adenocarcinoma 1 trial
- Ureter adenocarcinoma 1 trial
- Adenoacanthoma 0 trials
- Epididymal adenocarcinoma 0 trials
- Ethmoid sinus adenocarcinoma 0 trials
- Granular cell carcinoma 0 trials
- Intestinal type adenocarcinoma 0 trials Sub-types →
- Lacrimal gland adenocarcinoma 0 trials Sub-types →
- Maxillary sinus adenocarcinoma 0 trials
- Middle ear adenocarcinoma 0 trials
- Minor salivary gland adenocarcinoma 0 trials Sub-types →
- Rete testis adenocarcinoma 0 trials
- Salivary gland basal cell adenocarcinoma 0 trials
- Scirrhous adenocarcinoma 0 trials
- Submandibular gland adenocarcinoma 0 trials
- Thymus gland adenocarcinoma 0 trials Sub-types →
- Villous adenocarcinoma 0 trials Sub-types →
-
Digestive system carcinoma 25 trials · 4,876 incl. sub-types
16 sub-types
- Carcinoma of liver and intrahepatic biliary tract 36 trials · 1,455 incl. sub-types Sub-types →
- Colorectal carcinoma 305 trials · 1,166 incl. sub-types Sub-types →
- Exocrine pancreatic carcinoma 205 trials · 1,033 incl. sub-types Sub-types →
- Gastric carcinoma 92 trials · 554 incl. sub-types Sub-types →
- Gastroesophageal junction adenocarcinoma 506 trials
- Carcinoma of esophagus 75 trials · 504 incl. sub-types Sub-types →
- Carcinoma of pharynx 3 trials · 455 incl. sub-types Sub-types →
- Oral cavity carcinoma 16 trials · 200 incl. sub-types Sub-types →
- Small intestine carcinoma 19 trials · 105 incl. sub-types Sub-types →
- Gallbladder carcinoma 40 trials · 48 incl. sub-types Sub-types →
- Intestine carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Pancreatic endocrine carcinoma 12 trials Sub-types →
- Digestive system mixed adenoneuroendocrine carcinoma 0 trials · 3 incl. sub-types Sub-types →
- Carcinoma of floor of mouth 1 trial · 2 incl. sub-types Sub-types →
- Maxillary sinus carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Ameloblastic carcinoma 0 trials
-
Lung carcinoma 137 trials · 3,320 incl. sub-types
10 sub-types
- Non-small cell lung carcinoma 2,721 trials · 2,834 incl. sub-types Sub-types →
- Small cell lung carcinoma 514 trials · 515 incl. sub-types Sub-types →
- Squamous cell lung carcinoma 65 trials · 145 incl. sub-types Sub-types →
- Bronchogenic carcinoma 25 trials Sub-types →
- Lung carcinoma in situ 2 trials · 3 incl. sub-types Sub-types →
- Combined lung carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Asbestos-related lung carcinoma 0 trials
- Lung epithelial-myoepithelial carcinoma 0 trials
- Lung hilum carcinoma 0 trials
- Lung inflammatory myofibroblastic tumor 0 trials
-
Breast carcinoma 665 trials · 2,688 incl. sub-types
13 sub-types
- Breast carcinoma by gene expression profile 0 trials · 1,787 incl. sub-types Sub-types →
- Invasive breast carcinoma 324 trials · 412 incl. sub-types Sub-types →
- Breast adenocarcinoma 36 trials · 278 incl. sub-types Sub-types →
- Breast carcinoma in situ 76 trials · 204 incl. sub-types Sub-types →
- Female breast carcinoma 137 trials Sub-types →
- Male breast carcinoma 22 trials
- Hereditary breast carcinoma 10 trials Sub-types →
- Bilateral breast carcinoma 6 trials · 9 incl. sub-types Sub-types →
- Hormone-resistant breast carcinoma 5 trials
- Sporadic breast cancer 2 trials
- Ehrlich tumor carcinoma 0 trials
- Cribriform carcinoma of breast 0 trials Sub-types →
- Nipple carcinoma 0 trials Sub-types →
-
Squamous cell carcinoma 177 trials · 1,766 incl. sub-types
39 sub-types
- Head and neck squamous cell carcinoma 829 trials · 1,053 incl. sub-types Sub-types →
- Esophageal squamous cell carcinoma 303 trials · 304 incl. sub-types Sub-types →
- Skin squamous cell carcinoma 149 trials · 156 incl. sub-types Sub-types →
- Squamous cell lung carcinoma 65 trials · 145 incl. sub-types Sub-types →
- Human papillomavirus-related squamous cell carcinoma 115 trials · 116 incl. sub-types Sub-types →
- Colorectal squamous cell carcinoma 1 trial · 54 incl. sub-types Sub-types →
- Adenosquamous carcinoma 8 trials · 45 incl. sub-types Sub-types →
- Cervical squamous cell carcinoma 36 trials · 40 incl. sub-types Sub-types →
- Metastatic squamous cell carcinoma 39 trials
- Squamous cell carcinoma of penis 21 trials · 29 incl. sub-types Sub-types →
- Vulvar squamous cell carcinoma 22 trials Sub-types →
- Squamous cell carcinoma of pancreas 3 trials · 13 incl. sub-types Sub-types →
- Bone squamous cell carcinoma 0 trials · 11 incl. sub-types Sub-types →
- Squamous carcinoma in situ 5 trials · 10 incl. sub-types Sub-types →
- Vaginal squamous cell carcinoma 8 trials
- Basaloid squamous cell carcinoma 2 trials · 5 incl. sub-types Sub-types →
- Bladder squamous cell carcinoma 5 trials Sub-types →
- Gastric squamous cell carcinoma 4 trials Sub-types →
- Papillary squamous carcinoma 1 trial · 4 incl. sub-types Sub-types →
- Thyroid gland squamous cell carcinoma 4 trials
- Endometrial squamous cell carcinoma 0 trials · 2 incl. sub-types Sub-types →
- Ovarian squamous cell carcinoma 2 trials
- Urethra squamous cell carcinoma 2 trials Sub-types →
- Keratinizing squamous cell carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Pure squamous carcinoma of the urothelial tract 1 trial
- Scrotum squamous cell carcinoma 1 trial
- Squamous cell carcinoma of the small intestine 1 trial Sub-types →
- Ureter squamous cell carcinoma 1 trial
- Fallopian tube squamous cell carcinoma 0 trials
- Gallbladder squamous cell carcinoma 0 trials Sub-types →
- Prostate squamous cell carcinoma 0 trials Sub-types →
- Pseudoglandular squamous cell carcinoma 0 trials
- Renal pelvis squamous cell carcinoma 0 trials
- Sarcomatoid squamous cell carcinoma 0 trials Sub-types →
- Squamous cell breast carcinoma 0 trials Sub-types →
- Squamous cell carcinoma of liver and intrahepatic biliary tract 0 trials Sub-types →
- Squamous cell carcinoma of the corpus uteri 0 trials
- Thymus squamous cell carcinoma 0 trials Sub-types →
- Trachea squamous cell carcinoma 0 trials Sub-types →
-
Head and neck carcinoma 73 trials · 1,415 incl. sub-types
16 sub-types
- Head and neck squamous cell carcinoma 829 trials · 1,053 incl. sub-types Sub-types →
- Lip and oral cavity carcinoma 94 trials · 258 incl. sub-types Sub-types →
- Oropharyngeal carcinoma 99 trials · 242 incl. sub-types Sub-types →
- Nasopharyngeal carcinoma 210 trials · 211 incl. sub-types Sub-types →
- Hypopharyngeal carcinoma 35 trials · 86 incl. sub-types Sub-types →
- Nasal cavity and paranasal sinus carcinoma 21 trials · 44 incl. sub-types Sub-types →
- Nasal cavity carcinoma 3 trials · 9 incl. sub-types Sub-types →
- Eye carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Pituitary adenocarcinoma 3 trials Sub-types →
- Carcinoma of floor of mouth 1 trial · 2 incl. sub-types Sub-types →
- External ear carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Middle ear carcinoma 1 trial Sub-types →
- Ameloblastic carcinoma 0 trials
- Growth hormone-producing pituitary gland carcinoma 0 trials
- Laryngeal small cell carcinoma 0 trials
- Pharyngeal adenoid cystic carcinoma 0 trials
-
Prostate carcinoma 394 trials · 1,321 incl. sub-types
9 sub-types
- Metastatic prostate carcinoma 670 trials
- Castration-resistant prostate carcinoma 478 trials
- Prostate adenocarcinoma 297 trials Sub-types →
- Hormone-resistant prostate carcinoma 30 trials
- Prostate small cell carcinoma 9 trials
- Familial prostate carcinoma 0 trials
- Grade III prostatic intraepithelial neoplasia 0 trials
- Primary prostate urothelial carcinoma 0 trials Sub-types →
- Prostate squamous cell carcinoma 0 trials Sub-types →
-
Renal carcinoma 85 trials · 764 incl. sub-types
3 sub-types
- Renal cell carcinoma 611 trials · 710 incl. sub-types Sub-types →
- Renal pelvis carcinoma 15 trials · 22 incl. sub-types Sub-types →
- Kidney carcinoma in situ 0 trials Sub-types →
-
Neuroendocrine carcinoma 106 trials · 744 incl. sub-types
12 sub-types
- Small cell carcinoma 26 trials · 542 incl. sub-types Sub-types →
- Cutaneous neuroendocrine carcinoma 78 trials
- Medullary thyroid gland carcinoma 42 trials · 53 incl. sub-types Sub-types →
- Large cell neuroendocrine carcinoma 12 trials · 31 incl. sub-types Sub-types →
- Pancreatic endocrine carcinoma 12 trials Sub-types →
- Malignant adrenal gland pheochromocytoma 11 trials
- Liver neuroendocrine carcinoma 3 trials Sub-types →
- Thymic neuroendocrine carcinoma 3 trials Sub-types →
- Goblet cell carcinoma 2 trials
- Anal canal neuroendocrine neoplasm 1 trial Sub-types →
- Combined lung carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Vulvar neuroendocrine carcinoma 0 trials Sub-types →
-
Transitional cell carcinoma 249 trials · 721 incl. sub-types
9 sub-types
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Fallopian tube transitional cell carcinoma 12 trials
- Ovarian transitional cell carcinoma 12 trials
- Papillary transitional cell carcinoma 1 trial · 11 incl. sub-types Sub-types →
- Sarcomatoid transitional cell carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Bartholin gland transitional cell carcinoma 1 trial
- Endometrial transitional cell carcinoma 1 trial
- Primary prostate urothelial carcinoma 0 trials Sub-types →
- Transitional cell carcinoma of the corpus uteri 0 trials
-
Urinary bladder carcinoma 392 trials · 669 incl. sub-types
9 sub-types
- Bladder transitional cell carcinoma 130 trials · 408 incl. sub-types Sub-types →
- Superficial urinary bladder carcinoma 76 trials
- Stage IVb bladder cancer 39 trials
- Urinary bladder small cell neuroendocrine carcinoma 9 trials
- Bladder adenocarcinoma 5 trials · 8 incl. sub-types Sub-types →
- Bladder urachal carcinoma 3 trials · 6 incl. sub-types Sub-types →
- Bladder squamous cell carcinoma 5 trials Sub-types →
- Bladder small cell carcinoma 0 trials
- Childhood bladder carcinoma 0 trials
-
Malignant epithelial tumor of ovary 8 trials · 656 incl. sub-types
6 sub-types
- Ovarian carcinoma 493 trials · 642 incl. sub-types Sub-types →
- Malignant ovarian serous tumor 5 trials · 202 incl. sub-types Sub-types →
- Ovarian endometrial cancer 4 trials · 88 incl. sub-types Sub-types →
- Ovarian clear cell cancer 30 trials · 51 incl. sub-types Sub-types →
- Mucinous ovarian cancer 2 trials · 16 incl. sub-types Sub-types →
- Malignant ovarian Brenner tumor 2 trials
-
Uterine carcinoma 3 trials · 611 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- Endometrial carcinoma 207 trials · 313 incl. sub-types Sub-types →
- Endometrial serous adenocarcinoma 36 trials
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
-
Invasive carcinoma 4 trials · 604 incl. sub-types
4 sub-types
- Invasive breast carcinoma 324 trials · 412 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Invasive malignant thymoma 4 trials
- Submucosal invasive colon adenocarcinoma 0 trials
-
Peritoneal carcinoma 16 trials · 389 incl. sub-types
3 sub-types
- Primary peritoneal carcinoma 351 trials · 361 incl. sub-types Sub-types →
- Peritoneal serous adenocarcinoma 2 trials · 39 incl. sub-types Sub-types →
- Pseudomyxoma peritonei 17 trials
-
In situ carcinoma 25 trials · 318 incl. sub-types
21 sub-types
- Breast carcinoma in situ 76 trials · 204 incl. sub-types Sub-types →
- Adenocarcinoma in situ 10 trials · 170 incl. sub-types Sub-types →
- Bladder carcinoma in situ 30 trials
- Intestine carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Esophagus carcinoma in situ 13 trials
- Squamous carcinoma in situ 5 trials · 10 incl. sub-types Sub-types →
- Skin carcinoma in situ 3 trials · 9 incl. sub-types Sub-types →
- Oral cavity carcinoma in situ 5 trials Sub-types →
- Stomach carcinoma in situ 4 trials Sub-types →
- Lung carcinoma in situ 2 trials · 3 incl. sub-types Sub-types →
- Pharynx carcinoma in situ 0 trials · 2 incl. sub-types Sub-types →
- Larynx carcinoma in situ 1 trial Sub-types →
- Carcinoma in situ of ureter 0 trials
- Carcinoma in situ of urethra 0 trials
- Eye carcinoma in situ 0 trials
- Gall bladder carcinoma in situ 0 trials
- Grade III prostatic intraepithelial neoplasia 0 trials
- Kidney carcinoma in situ 0 trials Sub-types →
- Liver carcinoma in situ 0 trials Sub-types →
- Nasal cavity carcinoma in situ 0 trials
-
Skin carcinoma 34 trials · 281 incl. sub-types
13 sub-types
- Skin squamous cell carcinoma 149 trials · 156 incl. sub-types Sub-types →
- Cutaneous neuroendocrine carcinoma 78 trials
- Skin basal cell carcinoma 51 trials · 59 incl. sub-types Sub-types →
- Skin carcinoma in situ 3 trials · 9 incl. sub-types Sub-types →
- Anal margin carcinoma 1 trial · 6 incl. sub-types Sub-types →
- Skin appendage carcinoma 4 trials · 6 incl. sub-types Sub-types →
- Eyelid carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Cutaneous Paget disease 0 trials · 1 incl. sub-types Sub-types →
- Borst-Jadassohn intraepidermal carcinoma 0 trials
- Cutaneous mucoepidermoid carcinoma 0 trials
- Labia majora carcinoma 0 trials
- Labia minora carcinoma 0 trials
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Thyroid gland carcinoma 41 trials · 237 incl. sub-types
11 sub-types
- Differentiated thyroid carcinoma 79 trials · 182 incl. sub-types Sub-types →
- Thyroid gland adenocarcinoma 0 trials · 118 incl. sub-types Sub-types →
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Multiple endocrine neoplasia type 2 4 trials · 30 incl. sub-types Sub-types →
- Familial nonmedullary thyroid carcinoma 3 trials · 15 incl. sub-types Sub-types →
- Thyroid gland squamous cell carcinoma 4 trials
- Intrathyroid thymic carcinoma 0 trials
- Thyroid gland cribriform morular carcinoma 0 trials
- Thyroid gland mixed medullary and follicular cell-derived carcinoma 0 trials
- Thyroid gland mucinous carcinoma 0 trials
- Thyroid gland spindle cell tumor with thymus-like differentiation 0 trials
-
Fallopian tube carcinoma 126 trials · 182 incl. sub-types
6 sub-types
- Fallopian tube adenocarcinoma 4 trials · 81 incl. sub-types Sub-types →
- Fallopian tube transitional cell carcinoma 12 trials
- Fallopian tube carcinosarcoma 8 trials
- Fallopian tube gestational choriocarcinoma 0 trials
- Fallopian tube squamous cell carcinoma 0 trials
- Hereditary fallopian tube carcinoma 0 trials
-
Secondary carcinoma 1 trial · 169 incl. sub-types
1 sub-type
- Metastatic carcinoma 22 trials · 168 incl. sub-types Sub-types →
-
Bone carcinoma 0 trials · 131 incl. sub-types
7 sub-types
- Metastatic carcinoma in the bone 107 trials
- Paranasal sinus carcinoma 4 trials · 21 incl. sub-types Sub-types →
- Bone squamous cell carcinoma 0 trials · 11 incl. sub-types Sub-types →
- Pituitary adenocarcinoma 3 trials Sub-types →
- Adamantinoma 0 trials Sub-types →
- Growth hormone-producing pituitary gland carcinoma 0 trials
- Osteosarcoma arising in bone Paget disease 0 trials
-
Basal cell carcinoma 111 trials · 120 incl. sub-types
1 sub-type
- Skin basal cell carcinoma 51 trials · 59 incl. sub-types Sub-types →
-
Laryngeal carcinoma 56 trials · 114 incl. sub-types
8 sub-types
- Laryngeal squamous cell carcinoma 72 trials · 77 incl. sub-types Sub-types →
- Glottis carcinoma 6 trials · 10 incl. sub-types Sub-types →
- Carcinoma of supraglottis 1 trial · 2 incl. sub-types Sub-types →
- Larynx carcinoma in situ 1 trial Sub-types →
- Subglottis carcinoma 1 trial Sub-types →
- Laryngeal adenoid cystic carcinoma 0 trials
- Laryngeal mucoepidermoid carcinoma 0 trials
- Laryngeal small cell carcinoma 0 trials
-
Papillary carcinoma 8 trials · 112 incl. sub-types
5 sub-types
- Papillary adenocarcinoma 2 trials · 92 incl. sub-types Sub-types →
- Papillary transitional cell carcinoma 1 trial · 11 incl. sub-types Sub-types →
- Papillary squamous carcinoma 1 trial · 4 incl. sub-types Sub-types →
- Papillary carcinoma of the cervix uteri 0 trials Sub-types →
- Papillary carcinoma of the corpus uteri 0 trials
-
Large cell carcinoma 2 trials · 87 incl. sub-types
5 sub-types
- Lung large cell carcinoma 11 trials · 37 incl. sub-types Sub-types →
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Large cell neuroendocrine carcinoma 12 trials · 31 incl. sub-types Sub-types →
- Nasopharyngeal type undifferentiated carcinoma 2 trials · 3 incl. sub-types Sub-types →
- Salivary gland large cell carcinoma 0 trials
-
Undifferentiated carcinoma 6 trials · 80 incl. sub-types
14 sub-types
- Thyroid gland undifferentiated (anaplastic) carcinoma 35 trials
- Undifferentiated ovarian carcinoma 13 trials
- Endometrial undifferentiated carcinoma 9 trials
- Undifferentiated carcinoma of nasopharynx 7 trials
- Nut midline carcinoma 6 trials
- Sinonasal undifferentiated carcinoma 6 trials
- Undifferentiated carcinoma of esophagus 1 trial
- Undifferentiated carcinoma of liver and intrahepatic biliary tract 1 trial
- Undifferentiated carcinoma of stomach 1 trial
- Undifferentiated pancreatic carcinoma 1 trial Sub-types →
- Salivary gland large cell carcinoma 0 trials
- Thymic undifferentiated carcinoma 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
- Undifferentiated gallbladder carcinoma 0 trials
-
Mucin-producing carcinoma 0 trials · 58 incl. sub-types
2 sub-types
- Mucinous adenocarcinoma 18 trials · 57 incl. sub-types Sub-types →
- Pancreatic mucinous cystadenoma 1 trial
-
Retroperitoneum carcinoma 0 trials · 52 incl. sub-types
1 sub-type
- Adrenal carcinoma 34 trials · 52 incl. sub-types Sub-types →
-
Vulvar carcinoma 24 trials · 45 incl. sub-types
9 sub-types
- Vulvar squamous cell carcinoma 22 trials Sub-types →
- Vulvar adenocarcinoma 3 trials · 5 incl. sub-types Sub-types →
- Bartholin gland carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Clitoral carcinoma 0 trials
- Labia majora carcinoma 0 trials
- Labia minora carcinoma 0 trials
- Vulva basal cell carcinoma 0 trials
- Vulvar neuroendocrine carcinoma 0 trials Sub-types →
- Vulvar seborrheic keratosis 0 trials Sub-types →
-
Thymic carcinoma 41 trials · 44 incl. sub-types
9 sub-types
- Invasive malignant thymoma 4 trials
- Thymic neuroendocrine carcinoma 3 trials Sub-types →
- Lymphoepithelioma-like thymic carcinoma 0 trials
- Malignant type AB thymoma 0 trials
- Thymic sarcomatoid carcinoma 0 trials
- Thymic undifferentiated carcinoma 0 trials
- Thymus clear cell carcinoma 0 trials
- Thymus gland adenocarcinoma 0 trials Sub-types →
- Thymus squamous cell carcinoma 0 trials Sub-types →
-
Penile carcinoma 9 trials · 35 incl. sub-types
3 sub-types
- Squamous cell carcinoma of penis 21 trials · 29 incl. sub-types Sub-types →
- Paget disease of the penis 0 trials
- Penis basal cell carcinoma 0 trials
-
Sarcomatoid carcinoma 1 trial · 26 incl. sub-types
8 sub-types
- Sarcomatoid renal cell carcinoma 15 trials
- Lung sarcomatoid carcinoma 3 trials · 7 incl. sub-types Sub-types →
- Sarcomatoid transitional cell carcinoma 0 trials · 5 incl. sub-types Sub-types →
- Pleomorphic carcinoma 0 trials · 1 incl. sub-types Sub-types →
- Rectal sarcomatoid carcinoma 0 trials
- Sarcomatoid basal cell carcinoma 0 trials
- Sarcomatoid squamous cell carcinoma 0 trials Sub-types →
- Thymic sarcomatoid carcinoma 0 trials
-
Vaginal carcinoma 12 trials · 22 incl. sub-types
2 sub-types
- Vaginal squamous cell carcinoma 8 trials
- Vaginal adenocarcinoma 7 trials Sub-types →
-
Carcinoma of urethra 2 trials · 21 incl. sub-types
5 sub-types
- Urethra transitional cell carcinoma 17 trials Sub-types →
- Urethra adenocarcinoma 1 trial · 2 incl. sub-types Sub-types →
- Urethra squamous cell carcinoma 2 trials Sub-types →
- Littre gland carcinoma 0 trials Sub-types →
- Carcinoma in situ of urethra 0 trials
-
Ureter carcinoma 1 trial · 19 incl. sub-types
6 sub-types
- Ureter transitional cell carcinoma 16 trials Sub-types →
- Ureter adenocarcinoma 1 trial
- Ureter small cell carcinoma 1 trial
- Ureter squamous cell carcinoma 1 trial
- Carcinoma in situ of ureter 0 trials
- Regional ureteric cancer 0 trials
-
Choroid plexus carcinoma 11 trials
1 sub-type
-
Basaloid carcinoma 0 trials · 5 incl. sub-types
2 sub-types
- Basaloid squamous cell carcinoma 2 trials · 5 incl. sub-types Sub-types →
- Basaloid large cell lung carcinoma 0 trials
-
Cribriform carcinoma 1 trial · 4 incl. sub-types
2 sub-types
- Salivary duct carcinoma 3 trials
- Cribriform carcinoma of breast 0 trials Sub-types →
-
Malignant myoepithelioma 2 trials
1 sub-type
- Malignant breast myoepithelioma 0 trials
-
Combined carcinoid and adenocarcinoma 0 trials · 2 incl. sub-types
1 sub-type
- Goblet cell carcinoma 2 trials
-
Carcinoma ex pleomorphic adenoma 1 trial
2 sub-types
-
Trachea carcinoma 1 trial
3 sub-types
- Trachea mucoepidermoid carcinoma 0 trials
- Trachea squamous cell carcinoma 0 trials Sub-types →
- Tracheal adenoid cystic carcinoma 0 trials
-
Scrotal carcinoma 0 trials · 1 incl. sub-types
3 sub-types
- Scrotum squamous cell carcinoma 1 trial
- Scrotum Paget disease 0 trials
- Scrotum basal cell carcinoma 0 trials
-
Krebs 2 carcinoma 0 trials
-
Comedocarcinoma 0 trials
-
Epithelial-myoepithelial carcinoma 0 trials
2 sub-types
-
Glycogen-rich carcinoma 0 trials
1 sub-type
-
Lipid-rich carcinoma 0 trials
1 sub-type
- Lipid-rich breast carcinoma 0 trials
-
Lymph node carcinoma 0 trials
Most studied deeper sub-types
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New vaccine combo aims to halt prostate cancer growth without surgery
Disease control Not yet recruitingThis phase 2 trial tests a combination of a vaccine (TriAdeno) and an immune-boosting drug (N-803) in 52 men with early-stage, low- or medium-risk prostate cancer who are currently on active surveillance. The vaccine targets three proteins found in prostate cancer cells, while N-…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a two-drug combo outsmart resistant lung cancer?
Disease control Not yet recruitingThis phase 1 trial tests whether combining an experimental oral drug, JIN-A02, with an existing intravenous drug, amivantamab, is safe and can shrink tumors in people with advanced EGFR-mutant non-small cell lung cancer that has progressed after treatment with a third-generation …
Phase 1 • Sponsor: Yonsei University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a targeted pill shrink hard-to-treat bile duct cancers?
Disease control Not yet recruitingThis phase 2 trial tests whether daraxonrasib, an oral drug that targets cancers with a KRAS mutation, can shrink tumors in people with advanced biliary tract cancer that has progressed after first-line treatment. Participants take the drug once daily in 28-day cycles. The main g…
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Experimental vaccine cocktail targets rare liver cancer in early trial
Disease control Not yet recruitingThis early-stage trial tests a new vaccine that targets a specific protein found only in fibrolamellar liver cancer cells. The vaccine is combined with three other drugs to boost the immune system and block cancer growth. About 27 people with advanced disease who have already tri…
Phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a targeted radiation boost slow advanced lung cancer?
Disease control Not yet recruitingThis trial is testing whether giving radiotherapy to the main lung tumour, in addition to standard chemotherapy or immunotherapy, can reduce cancer spread and help people with metastatic non-small-cell lung cancer live longer. Around 420 adults with newly diagnosed stage IV lung …
Phase 3 • Sponsor: Trans Tasman Radiation Oncology Group • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can simulated High-Altitude breathing boost lung cancer treatment?
Disease control Not yet recruitingThis phase 2 trial tests whether adding intermittent hypoxic training (IHT) – short sessions of breathing low-oxygen air – to standard chemo-immunotherapy can improve outcomes for people with stage II-IIIA lung squamous cell carcinoma. About 60 participants will receive either st…
Phase 2 • Sponsor: zhang yi • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Heated chemo offers new hope for bladder cancer patients facing surgery
Disease control Not yet recruitingThis study tests a treatment called HIVEC, which delivers heated chemotherapy directly into the bladder. It is for people with a type of bladder cancer that has not responded to standard therapy and who cannot have their bladder removed. The goal is to see if this approach is saf…
Sponsor: AC.TA. S.r.l. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail shows promise in shrinking lung tumors before surgery
Disease control Not yet recruitingThis study tests a combination of two immune-boosting drugs (iparomlimab and tuvonralimab) plus chemotherapy given before surgery for people with a specific type of advanced lung cancer (stage III-N2b non-small cell lung cancer). The goal is to see if this treatment can completel…
Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Not yet recruitingThis study tests a new approach for people with liver cancer that cannot be removed by surgery. Doctors will use tiny drug-coated beads to block blood flow to the tumor (a procedure called TACE) along with a targeted pill called Donafenib. The goal is to see if this combination c…
Sponsor: Xuhua Duan • Aim: Disease control
Last updated Jun 26, 2026 18:09 UTC
-
Radioactive antibody aims to light up hidden solid tumors
Diagnosis Not yet recruitingResearchers are testing a new imaging agent called 111In-TJD-31 that targets placental alkaline phosphatase (ALPP), a protein found on many solid tumor cells but rarely in healthy adult tissue. The study enrolls 8 participants: 2 healthy volunteers who give blood samples and 6 pa…
Phase 1 • Sponsor: Yong He • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
New imaging agent aims to light up hidden tumors
Diagnosis Not yet recruitingThis early-stage study will test a new radioactive tracer called [89Zr]DFO-YS5 in 40 people with nerve sheath tumors, bladder cancer, or other advanced solid tumors. The tracer is designed to bind to cancer cells and show up on PET scans, potentially making tumors easier to see. …
Phase 1 • Sponsor: Robert Flavell, MD, PhD • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Daily aspirin may slash liver cancer risk in cirrhosis patients
Prevention Not yet recruitingThis study tests whether taking a low-dose aspirin (100 mg) every day can prevent liver cancer in people with cirrhosis, a condition that raises cancer risk. About 890 adults from Australian hospitals will take aspirin or a placebo for 4 years while continuing their regular check…
Phase 3 • Sponsor: Curtin University • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Canadian study aims to unlock secrets of cancer immunotherapy
Knowledge-focused Not yet recruitingThis study collects tumor tissue and blood samples from 120 cancer patients who are receiving or will receive immunotherapy. The samples will be stored in a biobank for future research to better understand how these treatments work. No direct treatment is given; the goal is to ga…
Sponsor: Canadian Cancer Trials Group • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists map cellular secrets of recurring colon polyps to prevent future cancer
Knowledge-focused Not yet recruitingThis study investigates why colorectal adenomas (precancerous polyps) sometimes return after being surgically removed. Researchers will collect tissue samples from 30 patients and use advanced genetic sequencing to compare polyps that recur with those that do not. The goal is to …
Sponsor: Zhongshan Hospital Xiamen University • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Scientists investigate if body fat and muscle change how radiation hits tumors
Knowledge-focused Not yet recruitingThis study looks at how a person's body composition—like muscle and fat levels—affects the radiation dose delivered to tumors and healthy organs during a targeted therapy for advanced prostate cancer. About 100 men with a specific type of prostate cancer will receive the standard…
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
MRI vs. CT: new study aims to sharpen cancer radiotherapy
Knowledge-focused Not yet recruitingThis study tests whether using MRI scans to plan radiotherapy is better than using CT scans alone. Researchers will work with up to 150 cancer patients and 15 healthy volunteers to see if MRI can make treatment more precise and reduce side effects. The goal is to improve how tumo…
Sponsor: Swansea Bay University Health Board • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New camera could spare skin cancer patients from unnecessary biopsies
Knowledge-focused Not yet recruitingThis study tests a non-invasive imaging technique called LC-OCT for diagnosing basal cell carcinoma, the most common skin cancer. Researchers will review medical records of about 300 patients to see if LC-OCT can accurately detect cancer and guide treatment without needing a biop…
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Hong kong researchers test affordable robot for colorectal surgery
Knowledge-focused Not yet recruitingThis study will test a new robotic surgical system, the Sentire Surgical System with a new Patient Side Single Arm, in 12 people needing colorectal surgery for cancer or large polyps. The goal is to see if the system is safe and effective, and if it can reduce costs compared to c…
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Protein fingerprint may forecast liver cancer 15 years early
Knowledge-focused Not yet recruitingThis study looks at stored liver biopsy samples from 30 people with MASH (a fatty liver disease) to see if a protein test can predict who will develop liver cancer within 15 years. Half of the participants later got liver cancer, and half did not. Researchers will compare the pro…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Could Omega-6 fats signal liver cancer risk?
Knowledge-focused Not yet recruitingThis observational study will measure Omega-6 fatty acid levels in the blood of 100 adults — half with liver cancer and half without — to see if there is a connection. No drugs or treatments are given. The goal is to understand if these fats are linked to the presence or severity…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC